Cargando…

Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study

This study was aimed at investigating Korean patients’ experience with bee venom therapy (BVT) and providing evidence to enhance BVT safety. Thus, an anonymous online survey was conducted between August 22 and 28, 2018. Five hundred respondents who underwent pharmacopuncture (PA) within one year wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyeonghan, Jeong, Hyein, Lee, Gihyun, Jang, Soobin, Yook, Taehan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780070/
https://www.ncbi.nlm.nih.gov/pubmed/35050995
http://dx.doi.org/10.3390/toxins14010018
_version_ 1784637740314263552
author Kim, Kyeonghan
Jeong, Hyein
Lee, Gihyun
Jang, Soobin
Yook, Taehan
author_facet Kim, Kyeonghan
Jeong, Hyein
Lee, Gihyun
Jang, Soobin
Yook, Taehan
author_sort Kim, Kyeonghan
collection PubMed
description This study was aimed at investigating Korean patients’ experience with bee venom therapy (BVT) and providing evidence to enhance BVT safety. Thus, an anonymous online survey was conducted between August 22 and 28, 2018. Five hundred respondents who underwent pharmacopuncture (PA) within one year were surveyed (sample error: 95 ± 4.38%). Of these, 32 respondents were excluded and 468 were evaluated. Of the 468, 61 reported experiencing adverse events after PA. The adverse event rate was higher in the BV-PA(Bee venom-Pharmacopuncture) group than in the non-A group; however, intergroup differences were insignificant. There were no significant differences in mild symptom intensity between the BV-PA and non-BV-PA groups (p = 0.572). However, there was a significant intergroup difference in severe symptom intensity (p < 0.001). Additionally, the BV-PA and non-BV-PA groups did not significantly differ in their level of satisfaction either overall or in terms of effectiveness and safety (p = 0.414, p = 0.339, and p = 0.675, respectively). Furthermore, the BV-PA and non-BV-PA groups did not differ regarding intent to re-treat (p = 0.722). Severe adverse events such as anaphylactic shock were not reported; however, BVT practitioners should be cautious when applying it.
format Online
Article
Text
id pubmed-8780070
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87800702022-01-22 Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study Kim, Kyeonghan Jeong, Hyein Lee, Gihyun Jang, Soobin Yook, Taehan Toxins (Basel) Article This study was aimed at investigating Korean patients’ experience with bee venom therapy (BVT) and providing evidence to enhance BVT safety. Thus, an anonymous online survey was conducted between August 22 and 28, 2018. Five hundred respondents who underwent pharmacopuncture (PA) within one year were surveyed (sample error: 95 ± 4.38%). Of these, 32 respondents were excluded and 468 were evaluated. Of the 468, 61 reported experiencing adverse events after PA. The adverse event rate was higher in the BV-PA(Bee venom-Pharmacopuncture) group than in the non-A group; however, intergroup differences were insignificant. There were no significant differences in mild symptom intensity between the BV-PA and non-BV-PA groups (p = 0.572). However, there was a significant intergroup difference in severe symptom intensity (p < 0.001). Additionally, the BV-PA and non-BV-PA groups did not significantly differ in their level of satisfaction either overall or in terms of effectiveness and safety (p = 0.414, p = 0.339, and p = 0.675, respectively). Furthermore, the BV-PA and non-BV-PA groups did not differ regarding intent to re-treat (p = 0.722). Severe adverse events such as anaphylactic shock were not reported; however, BVT practitioners should be cautious when applying it. MDPI 2021-12-27 /pmc/articles/PMC8780070/ /pubmed/35050995 http://dx.doi.org/10.3390/toxins14010018 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Kyeonghan
Jeong, Hyein
Lee, Gihyun
Jang, Soobin
Yook, Taehan
Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study
title Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study
title_full Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study
title_fullStr Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study
title_full_unstemmed Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study
title_short Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study
title_sort characteristics of adverse events in bee venom therapy reported in south korea: a survey study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780070/
https://www.ncbi.nlm.nih.gov/pubmed/35050995
http://dx.doi.org/10.3390/toxins14010018
work_keys_str_mv AT kimkyeonghan characteristicsofadverseeventsinbeevenomtherapyreportedinsouthkoreaasurveystudy
AT jeonghyein characteristicsofadverseeventsinbeevenomtherapyreportedinsouthkoreaasurveystudy
AT leegihyun characteristicsofadverseeventsinbeevenomtherapyreportedinsouthkoreaasurveystudy
AT jangsoobin characteristicsofadverseeventsinbeevenomtherapyreportedinsouthkoreaasurveystudy
AT yooktaehan characteristicsofadverseeventsinbeevenomtherapyreportedinsouthkoreaasurveystudy